Zhongchao Inc. (ZCMD), a healthcare and internet technology company, said it will implement a 1-for-31 share consolidation effective June 8, 2026, to maintain compliance with Nasdaq Capital Market listing requirements.
Zhongchao Inc. (ZCMD), a healthcare information and service provider, priced its best-efforts public offering of 9.26 million units, each consisting of one Class A ordinary Share (or a pre-funded warrant in lieu thereof) and one warrant to purchase one Class A ordinary share at a combined price of $0.54...
Several biotech and healthcare stocks posted notable after-hours gains on Wednesday, October 1, with price action largely driven by technical momentum and recent clinical updates rather than fresh disclosures. While most companies did not issue new filings or press releases during the session, earlier...
In Monday's pre-market trading, the biotech stocks which are making significant moves are : (as of 8.00 am ET).
The following are some of the stocks making big moves in pre-market trading (as of 8:40 AM EDT)
August 13, 2026 05:33 ET The World Health Organization’s cancer research agency, the International Agency for Research on Cancer (IARC), has classified three widely used medicines as carcinogenic to humans.